Blend Labs (BLND) Financials

Blend Labs (NYSE: BLND) shows a business that has improved meaningfully from the deep losses of 2022 and 2023, but Q1 2026 was still unprofitable and cash flow turned negative again. Revenue is far below the company’s 2022 peak, yet the cost structure is much leaner than it was two years ago. The balance sheet still shows a sizable cash position and short-term investments, but common equity remains negative, which is a sign of past accumulated losses.

• Operating revenue has stabilized around $30 million per quarter in the last several quarters, compared with the much larger swings seen in 2022 and 2023. That suggests a more predictable top line.
• Gross margin remains strong: Q1 2026 gross profit was $23.4 million on $30.8 million of revenue, or roughly 76%. That gives Blend a solid cushion before operating expenses.
• Operating losses have narrowed sharply versus earlier years. Q1 2026 operating loss was $5.1 million, much better than the massive losses seen in 2022 and early 2023.
• Balance sheet liquidity remains meaningful, with $37.4 million in cash and $21.6 million in short-term investments at the end of Q1 2026.
• Total current assets of $93.1 million still exceed current liabilities of $51.5 million, giving the company near-term flexibility.
• Capital spending is relatively modest. Q1 2026 capex was only $1.1 million, which helps preserve cash.
• Q1 2026 revenue was down slightly sequentially from Q4 2025 ($30.8 million vs. $32.4 million), so growth has not reaccelerated yet.
• Other income can swing earnings dramatically. In some quarters, investment gains and other non-operating items have meaningfully boosted results, while in others they faded. That makes bottom-line trends less predictable.
• Share count remains high, with weighted average diluted shares of 255.6 million in Q1 2026. Dilution is still an important factor for per-share value.
• The company also carries a redeemable noncontrolling interest, which complicates the equity picture and helps explain why common equity is negative.
• Q1 2026 was still loss-making, with a net loss of $8.0 million and a loss of $12.8 million attributable to common shareholders.
• Operating cash flow weakened materially in Q1 2026, falling to $7.4 million from $0.98 million in Q4 2025 and turning negative in several prior periods.
• Financing cash outflow was heavy in Q1 2026, including $16.8 million of common-equity repurchases, which reduced cash despite positive operating and investing inflows.
• Common equity remains negative at -$55.9 million, reflecting the company’s accumulated losses over time.
• Revenue is still well below 2022 levels. Quarterly revenue was above $40 million in parts of 2022, so the current run rate is much smaller than the company’s earlier scale.

Bottom line: Blend Labs appears to be a more disciplined business than it was a few years ago, with better margins and a healthier liquidity position. But investors should still view it as a turnaround story: the company has not yet proven consistent profitability, and cash generation can be uneven quarter to quarter.